Department of Cell Biology, University of Alberta, Edmonton, Canada.
Department of Medicine, University of Alberta, Edmonton, Canada.
J Infect Dis. 2019 Sep 13;220(8):1377-1387. doi: 10.1093/infdis/jiz073.
Zika virus (ZIKV) is an emerging pathogen that can cause microcephaly and other neurological defects in developing fetuses. The cellular response to ZIKV in the fetal brain is not well understood. Here, we show that ZIKV infection of human fetal astrocytes (HFAs), the most abundant cell type in the brain, results in elevated expression and secretion of fibroblast growth factor 2 (FGF2). This cytokine was shown to enhance replication and spread of ZIKV in HFAs and human fetal brain explants. The proviral effect of FGF2 is likely mediated in part by suppression of the interferon response, which would represent a novel mechanism by which viruses antagonize host antiviral defenses. We posit that FGF2-enhanced virus replication in the fetal brain contributes to the neurodevelopmental disorders associated with in utero ZIKV infection. As such, targeting FGF2-dependent signaling should be explored further as a strategy to limit replication of ZIKV.
寨卡病毒(ZIKV)是一种新兴的病原体,可导致发育中的胎儿出现小头症和其他神经缺陷。人们对胎儿大脑中 ZIKV 的细胞反应还了解甚少。在这里,我们发现 ZIKV 感染人胎儿星形胶质细胞(HFAs)——大脑中最丰富的细胞类型,会导致成纤维细胞生长因子 2(FGF2)的表达和分泌增加。这种细胞因子被证明可以增强 ZIKV 在 HFAs 和人胎儿脑外植体中的复制和传播。FGF2 的前病毒作用可能部分通过抑制干扰素反应来介导,这代表了病毒拮抗宿主抗病毒防御的一种新机制。我们假设 FGF2 增强胎儿大脑中的病毒复制导致了与宫内 ZIKV 感染相关的神经发育障碍。因此,进一步探索靶向 FGF2 依赖性信号传导作为限制 ZIKV 复制的策略应该是有意义的。